D-0010-2016 Class II Terminated

Recalled by Nephron Pharmaceuticals Corp. — Orlando, FL

Recall Details

Product Type
Drugs
Report Date
October 21, 2015
Initiation Date
August 21, 2015
Termination Date
February 10, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 85,248 cartons and b) 35,292 cartons

Product Description

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL

Reason for Recall

Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process

Distribution Pattern

Nationwide

Code Information

a) Lot D4E20A, exp 3/2016 and b) Lot D4C21A, exp 3/2016